Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 688

Similar articles for PubMed (Select 18955515)

1.

Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

Ritz N, Tebruegge M, Connell TG, Sievers A, Robins-Browne R, Curtis N.

Antimicrob Agents Chemother. 2009 Jan;53(1):316-8. doi: 10.1128/AAC.01302-08. Epub 2008 Oct 27.

2.

Antituberculous drug susceptibility testing of Mycobacterium bovis BCG strain Montréal.

Rousseau P, Dupuis M.

Can J Microbiol. 1990 Oct;36(10):735-7.

PMID:
2253115
3.

Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.

Shishido Y, Mitarai S, Otomo K, Seki M, Sato A, Yano I, Koyama A, Hattori T.

Int J Tuberc Lung Dis. 2007 Dec;11(12):1334-8.

PMID:
18034955
4.

In vitro drug susceptibility of Mycobacterium bovis BCG Connaught and Tokyo strains.

Shimizu T, Yasumoto K, Tatano Y, Tomioka H, Sato K, Sano C, Kumon H, Monden K.

J Infect. 2010 Mar;60(3):248-51. doi: 10.1016/j.jinf.2010.01.002. Epub 2010 Jan 13. No abstract available.

PMID:
20074586
5.

Cytochemical and biological properties of Mycobacterium bovis BCG.

Slosárek M.

Folia Microbiol (Praha). 1977;22(4):262-8.

PMID:
330364
6.

Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates.

Kolibab K, Derrick SC, Morris SL.

J Clin Microbiol. 2011 Jun;49(6):2380-1. doi: 10.1128/JCM.00648-11. Epub 2011 Apr 20. No abstract available.

7.

A point mutation in cycA partially contributes to the D-cycloserine resistance trait of Mycobacterium bovis BCG vaccine strains.

Chen JM, Uplekar S, Gordon SV, Cole ST.

PLoS One. 2012;7(8):e43467. doi: 10.1371/journal.pone.0043467. Epub 2012 Aug 17.

8.

[Isolation of mutants resistant to antituberculous drugs in wild strains of M. bovis].

de Kantor IN, Lesslie IW.

Medicina (B Aires). 1974 May-Jun;34(3):244-8. Spanish. No abstract available.

PMID:
4212693
10.

Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected children.

Hesseling AC, Schaaf HS, Victor T, Beyers N, Marais BJ, Cotton MF, Wiid I, Gie RP, van Helden P, Warren RM.

Pediatr Infect Dis J. 2004 May;23(5):476-9.

PMID:
15131480
11.

Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.

Khan A, Sarkar S, Sarkar D.

Int J Antimicrob Agents. 2008 Jul;32(1):40-5. doi: 10.1016/j.ijantimicag.2008.02.022. Epub 2008 Jun 5.

PMID:
18538548
12.

Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques.

Parreiras PM, Lobato FC, Alencar AP, Figueiredo Td, Gomes HM, Boéchat N, Lage AP, Assis RA, Pereira MA, Souza PR, Mota PM, Suffys PN.

Mem Inst Oswaldo Cruz. 2004 Nov;99(7):749-52. Epub 2005 Jan 12.

13.

In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG.

Murugasu-Oei B, Dick T.

Int J Antimicrob Agents. 2001 Dec;18(6):579-82.

PMID:
11738349
14.

Mapping the global use of different BCG vaccine strains.

Ritz N, Curtis N.

Tuberculosis (Edinb). 2009 Jul;89(4):248-51. doi: 10.1016/j.tube.2009.03.002. Epub 2009 Jun 18.

PMID:
19540166
15.

Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG.

Ramón-García S, Martín C, De Rossi E, Aínsa JA.

J Antimicrob Chemother. 2007 Mar;59(3):544-7. Epub 2007 Jan 22.

16.

Recombinant Mycobacterium bovis BCG.

Bastos RG, Borsuk S, Seixas FK, Dellagostin OA.

Vaccine. 2009 Nov 5;27(47):6495-503. doi: 10.1016/j.vaccine.2009.08.044. Epub 2009 Aug 29. Review.

PMID:
19720367
17.

Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.

Chen JM, Islam ST, Ren H, Liu J.

Vaccine. 2007 Nov 23;25(48):8114-22. Epub 2007 Oct 8.

PMID:
17954004
18.

BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.

Liu J, Tran V, Leung AS, Alexander DC, Zhu B.

Hum Vaccin. 2009 Feb;5(2):70-8. Epub 2009 Feb 20. Review.

PMID:
19164935
19.

[Distribution of the range of natural sensitivity to antitubercular preparations in cultures of strains of mycobacterum BCG].

Kulikova MF.

Antibiotiki. 1968 Jul;13(7):642-7. Russian. No abstract available.

PMID:
4301383
20.

[Application of multiplex polymerase chain reaction in rapid identification of Mycobacterium bovis BCG].

Li GL, Chen BW, Zhuang YH, Wang GZ, Zhao M, Shen XB, Sun GZ.

Zhonghua Jie He He Hu Xi Za Zhi. 2003 Nov;26(11):701-3. Chinese.

PMID:
14703448
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk